-
Mashup Score: 1Research identifies predictor of outcomes, chemoresistance for ovarian cancer patients | MDLinx - 2 month(s) ago
Published February 28, 2024 | Originally published on MedicalXpress Breakin g News-and-Events Key points summarized by the MDLinx Team. Newly published research from an international consortium led by the University of Minnesota’s Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment. Published in JAMA Network Open, the findings indicate that ovarian cancer patients with high levels of stroma within their tumors are twice as likely to exhibit chemoresistance to
Source: www.mdlinx.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 010,000 Minnesotans will die of cancer in 2024 - Minnesota Reformer - 3 month(s) ago
Close to 38,000 Minnesotans will be diagnosed with cancer in 2024, according to the latest projections from the American Cancer Society. Over 5,000 women will learn they have breast cancer. A similar number of men will get diagnosed with prostate cancer. The good news, if you want to call it that, is that Minnesotans are […]
Source: minnesotareformer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Count Me In - 4 month(s) ago
Have a direct impact on the future of colorectal cancer. If you have ever been diagnosed with colorectal cancer, join a nationwide movement of patients to contribute your samples, your medical records, and your voice to colorectal cancer research. Together, we can speed the development of future therapies. Join Count Me In …
Source: joincountmein.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
Background Determination of programmed death-ligand 1 (PD-L1) protein expression level in tumor cells and tumor-associated immune cells is critical for identifying patients eligible for immunotherapy. PD-L1 manual scoring algorithms can generally be divided into two categories: cell counting and visual estimation. Cell counting can be time-consuming and is not in sync with pathology practice, which classically uses a Gestalt approach based on pattern recognition and visual estimation. In this study, we introduce the Tumor Area Positivity (TAP) score, which is a novel, straightforward method for scoring tumor cells and immune cells together using visual estimation. Methods To demonstrate the reproducibility of TAP scoring among pathologists, between- and within-reader precision studies were performed both within (internal) and outside of (external) our organization. We also compared the TAP score to the Combined Positive Score (CPS), which is based on cell counting, for concordance and
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
Our study showed the TAP scoring method to be straightforward, significantly less time-consuming, and highly reproducible with a high concordance rate between TAP score and CPS.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Cancer patients face frightening delays in treatment approvals - 5 month(s) ago
Many cancer patients have had oncology care delayed because of prior authorization hurdles, with some facing delays of more than two weeks.
Source: fortune.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1New Year Celebration In Different Countries - 5 month(s) ago
As you know, every country and every nation has its own national traditions, related to the celebration of various holidays. Sometimes these traditions are v…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Imaging across scales - 5 month(s) ago
New twists on established methods and multimodal imaging are poised to bridge gaps between cellular and organismal imaging.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Interview with Dr. Emil Lou: Pathogens and Cancer Associations - 5 month(s) ago
Join Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance, in a captivating podcast conversation with special guest Dr. Emil Lou, Associate Professor of Medicine at the University of Mi
Source: soundcloud.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24NANETS Monthly Programming Series: NETS: Under the Microscope - 5 month(s) ago
The North American Neuroendocrine Tumor Society (NANETS) offers comprehensive, accredited medical education programs on NET disease that are developed by leading NET experts and designed exclusively for medical professionals. We also provide research grants, travel grants and education grants to young investigators doing preeminent work in the field of NET research. Visit our website to learn how you can get involved or to make a donation today!
Source: nanets.netCategories: General Medicine News, Hem/OncsTweet
https://t.co/8PxkP8BkQI